Clinical Trial Update: A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 2]

View source ↗

Summary

Phase 2 pediatric NAFLD trial evaluating acarbose has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Precose (acarbose)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: TERMINATED